Article
13 Aug 2025
FDA Calls For Stronger Industry Collaboration On Infant And Child Food Recalls
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
09 Jun 2025
GLP-1 Compounded Medications Targeted By Connecticut Attorney General
Article
05 Apr 2025
Texas Court Vacates FDA's Laboratory Developed Test (LDT) Final Rule
Article
19 Mar 2025
Compounded GLP-1 Drugs: Texas Judge Denies PI Motion And Request For Stay Of FDA's Declaration That Tirzepatide Shortage Is Resolved; Plaintiff OFA Appeals
Article
20 Jan 2025
AI Drug Development: FDA Releases Draft Guidance
Article
09 Jan 2025
AI-Enabled Device Software Functions: FDA's Final Guidance For Predetermined Change Control Plans
Article
02 Jan 2025
GLP-1 Drugs: FDA "Re-Confirms" Decision Removing Tirzepatide From The Drug Shortage List
Article
27 Dec 2024
FDA Targets GLP-1 Providers With Warning Letters
Article
17 Dec 2024
Antibody Drug Conjugates Keep Growing: What You Need To Know
Article
03 Dec 2024
GLP-1 Drugs: Brand Companies Push FDA To Limit Compounding
Article
25 Oct 2024
GLP-1 Drugs: FDA Sued Over Removing Tirzepatide From The Drug Shortage List
Article
09 Oct 2024
GLP-1 Drugs: FDA Removes Lilly's Zepbound® And Mounjaro® (Tirzepatide Injection) From Its Drug Shortage List
Article
21 May 2024
The Laws Of Fashion: What's Trending In 2024
Article
20 May 2024
Keeping Track Of Your Data — What You Need To Know About FDA's Draft Guidance On Data Integrity For In Vivo Bioavailability And Bioequivalence Studies
Article
09 May 2024
2024 Health Care & Life Sciences Top Trends - Driving Tomorrow's Advances In The Health Care And Life Sciences Ecosystems
Article
11 Apr 2024
Cancer Drugs (Antibody Drug Conjugates): An FDA Perspective
Article
16 Jan 2024
FDA: Major Policy Shift Authorizes Florida's Plan To Import Drugs From Canada
Article
04 Dec 2023
FDA Issues Tip Sheet To Shore-Up The Supply Chain For Infant Formula And Critical Food
Article
22 Nov 2023
Revisiting FDA's Original Guidance On Orange Book Listability In Light Of Heightened FTC Scrutiny
Article
16 Nov 2023
A Look At FDA's Proposed Changes To Labeling For Biosimilars And Interchangeable Biosimilars
